Uttar Pradesh, India

Archana Gupta

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Archana Gupta. Retrieved from https://idiyas.com/inventor/archana-gupta-uo6848w1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Archana Gupta: Innovator in Aldosterone Synthase Inhibitors

Introduction

Archana Gupta is a prominent inventor based in Uttar Pradesh, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of aldosterone synthase inhibitors. Her work is crucial for addressing health issues related to elevated aldosterone levels.

Latest Patents

Archana Gupta holds one patent for her invention involving aldosterone synthase inhibitors. The patent describes compounds of structural Formula (I) and their pharmaceutically acceptable salts. These compounds are effective at selectively inhibiting CYP11B2, making them useful for the treatment or prophylaxis of disorders associated with elevated aldosterone levels, including hypertension and heart failure.

Career Highlights

Archana Gupta is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. Her role at Merck has allowed her to further her research and development efforts in the pharmaceutical industry.

Collaborations

Throughout her career, Archana has collaborated with notable professionals in her field, including Scott B Hoyt and Min K Park. These collaborations have enhanced her research and contributed to the advancement of her inventions.

Conclusion

Archana Gupta's innovative work in aldosterone synthase inhibitors showcases her dedication to improving healthcare solutions. Her contributions are vital for the treatment of serious health conditions, and her ongoing research promises to make a significant impact in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…